Farallon Capital Management, L.l.c.

San Francisco, CA 87 processed 13Fs on this site, 2021 Q3 to 2026 Q2

$21.7B
77 holdings
2026 Q2
+23.6% QoQ
Top 5 29.9%

Portfolio

2026 Q2, filed 8/14/2026, top 12 of 77 holdings

Top 5 29.9%, top 10 44.0%

AUM over time

2026 Q2 $21.7B +23.6% QoQ

Q3 2021

Q1 2022

Q1 2023

Q1 2024

Q1 2025

Q1 2026

Book

2024 Q2 2024 Q1, filed 14 Aug, long equity only

Download CSV Download Excel All activity


UNH, UnitedHealth Group	3.89%	Reduce −4.9%	1,618,200	$509.26	$824M	−83,210	−$18M
CRM, Salesforce	3.58%, was 2.66%	Add +51.0%	2,946,838	$257.10	$758M	+994,670	+$170M
IQV, IQVIA	2.92%	Add +3.1%	2,923,032	$211.44	$618M	+86,870	−$99M
EXEL, Exelixis	2.87%, was 2.86%	Add +1.6%	27,102,500	$22.47	$609M	+424,000	−$24M
ARMK, Aramark	2.72%	Reduce −5.0%	16,929,237	$34.02	$576M	−893,700	−$3.7M
AON, Aon	2.60%, was 0.95%	Add +196.7%	1,875,200	$293.58	$551M	+1,243,200	+$340M
MSFT, Microsoft	2.54%	Reduce −0.7%	1,202,778	$446.95	$538M	−8,680	+$28M
NYT, New York Times	2.40%	Reduce −11.3%	9,919,840	$51.21	$508M	−1,268,219	+$24M
NTRA, Natera	2.28%, was 1.62%	Add +13.6%	4,460,557	$108.29	$483M	+532,874	+$124M
NDAQ, Nasdaq	2.13%, was 2.41%	Reduce −11.0%	7,506,719	$60.26	$452M	−930,000	−$80M
TRU, Transunion	2.11%, was 2.29%	Reduce −5.0%	6,035,119	$74.16	$448M	−316,137	−$59M
INTU, Intuit	1.95%, was 1.58%	Add +17.1%	629,097	$657.21	$413M	+92,019	+$64M
TMO, Thermo Fisher Scientific	1.93%, was 2.10%	Reduce −7.3%	739,156	$553.00	$409M	−58,260	−$55M
RVMD, Revolution Medicines	1.79%, was 1.09%	Add +30.0%	9,757,692	$38.81	$379M	+2,249,820	+$137M
Sarepta Therapeutics	1.71%	Reduce −6.5%	2,295,000	$158.00	$363M	−158,500	+$45M
NOW, ServiceNow	1.69%, was 1.36%	Add +14.9%	454,050	$786.67	$357M	+58,962	+$56M
DIS, Disney	1.68%	New	3,582,168	$99.29	$356M	+3,582,168	+$356M
SPGI, S&P Global	1.65%	Reduce −1.5%	781,934	$446.00	$349M	−11,910	+$11M
WAB, Wabtec	1.63%, was 1.95%	Reduce −25.9%	2,189,498	$158.05	$346M	−766,900	−$85M
CBRE, CBRE Group	1.59%, was 1.84%	Reduce −9.8%	3,773,000	$89.11	$336M	−411,030	−$71M
GOOG, Alphabet	1.55%, was 2.30%	Reduce −46.2%	1,796,540	$183.42	$330M	−1,541,410	−$179M
BSX, Boston Scientific	1.49%	Reduce −10.6%	4,109,157	$77.01	$316M	−487,500	+$1.6M
ADI, Analog Devices	1.38%	Reduce −16.5%	1,284,800	$228.26	$293M	−253,190	−$11M
ABNB, Airbnb	1.22%, was 1.20%	Add +5.8%	1,701,000	$151.63	$258M	+92,780	−$7.4M
AGIO, Agios Pharmaceuticals	1.15%, was 0.74%	Add +1.1%	5,654,502	$43.12	$244M	+63,900	+$80M
V, Visa	1.02%, was 0.86%	Add +20.7%	821,886	$262.47	$216M	+141,036	+$26M
YMM, Full Truck Alliance	0.98%	Reduce −1.7%	25,850,303	$8.04	$208M	−434,756	+$17M
MA, Mastercard	0.96%, was 1.12%	Reduce −9.8%	462,771	$441.16	$204M	−50,390	−$43M
PTGX, Protagonist Therapeutics	0.96%, was 0.75%	Add +1.8%	5,840,773	$34.65	$202M	+101,800	+$36M
HWM, Howmet Aerospace	0.93%, was 1.06%	Reduce −25.5%	2,541,839	$77.63	$197M	−868,920	−$36M
SHW, Sherwin-Williams	0.91%, was 1.18%	Reduce −14.1%	647,550	$298.43	$193M	−106,280	−$69M
AZNN	0.89%, was 0.45%	Add +65.1%	2,409,718	$77.99	$188M	+950,000	+$89M
BEAM, Beam Therapeutics	0.87%, was 0.67%	Add +75.4%	7,913,123	$23.43	$185M	+3,401,370	+$36M
LNTH, Lantheus	0.86%, was 0.42%	Add +53.7%	2,279,227	$80.29	$183M	+796,000	+$91M
CNC, Centene	0.68%, was 0.93%	Reduce −16.9%	2,168,175	$66.30	$144M	−439,700	−$61M
Masimo	0.67%, was 0.99%	Reduce −24.8%	1,119,563	$125.94	$141M	−370,000	−$78M
EDU	0.54%, was 0.24%	Add +139.0%	1,469,590	$77.73	$114M	+854,590	+$61M
THC, Tenet Healthcare	0.43%, was 0.30%	Add +7.8%	687,442	$133.03	$91M	+50,000	+$24M
Holding	0.38%, was 0.57%	Reduce −49.2%	2,940,500	$27.03	$79M	−2,850,000	−$46M
BHVN, Biohaven	0.37%, was 0.20%	Add +181.4%	2,248,000	$34.71	$78M	+1,449,000	+$34M
AMGN, Amgen	0.34%	New	232,000	$312.45	$72M	+232,000	+$72M
GERN, Geron	0.34%, was 0.11%	Add +124.6%	16,837,000	$4.24	$71M	+9,342,000	+$47M
BEKE, KE Holdings	0.32%	Hold	4,740,833	$14.15	$67M	—	—
ICLR, Icon	0.26%, was 0.27%	Reduce −0.8%	178,200	$313.47	$56M	−1,500	−$4.5M
COR, Cencora	0.26%, was 0.37%	Reduce −27.3%	242,800	$225.30	$55M	−91,200	−$26M
Holding	0.23%	New	1,190,000	$40.89	$49M	+1,190,000	+$49M
SIMO, Silicon Motion Technology	0.22%, was 0.30%	Reduce −33.7%	567,534	$80.99	$46M	−287,915	−$20M
UTHR, United Therapeutics	0.21%, was 0.11%	Add +30.0%	143,000	$318.55	$46M	+33,000	+$20M
INSM, Insmed	0.18%	New	568,000	$67.00	$38M	+568,000	+$38M
PGNY, Progyny	0.18%, was 0.10%	Add +120.8%	1,308,500	$28.61	$37M	+715,900	+$15M
FLUT, Flutter Entertainment	0.17%	New	200,800	$182.36	$37M	+200,800	+$37M
CRSP, Crispr Therapeutics	0.14%	New	530,000	$54.01	$29M	+530,000	+$29M
ENTA, Enanta Pharmaceuticals	0.13%	Hold	2,095,000	$12.97	$27M	—	—
LQDA, Liquidia	0.12%	Hold	2,055,000	$12.00	$25M	—	—
CRNX	0.11%	Add +9840.0%	497,000	$44.79	$22M	+492,000	+$22M
PCVX, Vaxcyte	0.10%, was 0.12%	Reduce −23.2%	290,000	$75.51	$22M	−87,400	−$3.9M
Savara	0.09%, was 0.05%	Add +90.5%	4,560,000	$4.03	$18M	+2,165,701	+$6.5M
VYGR, Voyager Therapeutics	0.09%	Hold	2,292,000	$7.91	$18M	—	—
CNTA, Centessa Pharmaceuticals	0.09%, was 0.02%	Add +438.0%	1,996,000	$9.03	$18M	+1,625,000	+$14M
SYRE, Spyre Therapeutics	0.07%	Add +42.9%	666,000	$23.51	$16M	+200,000	−$2M
TAL, Tal Education Group	0.07%	Hold	1,365,000	$10.67	$15M	—	—
Zymeworks	0.06%	Hold	1,601,000	$8.51	$14M	—	—
PCG, PG&E	0.06%, was 0.10%	Reduce −45.6%	692,323	$17.46	$12M	−579,319	−$9.2M
GDS, GDS Holdings	0.05%, was 0.02%	Add +72.7%	1,226,133	$9.29	$11M	+516,133	+$6.7M
Elevation Oncology	0.05%, was 0.09%	Reduce −7.4%	3,598,418	$2.70	$9.7M	−288,245	−$10M
TWST, Twist Bioscience	0.04%	New	192,000	$49.28	$9.5M	+192,000	+$9.5M
RIO, Rio Tinto	0.04%	Hold	137,500	$65.93	$9.1M	—	—
Ventyx Biosciences	0.03%	Hold	3,170,000	$2.31	$7.3M	—	—
ROIV, Roivant Sciences	0.03%, was 0.04%	Reduce −25.1%	673,000	$10.57	$7.1M	−225,600	−$2.4M
TECX, Tectonic Therapeutic	0.03%	New	431,010	$16.47	$7.1M	+431,010	+$7.1M
Helix Acquisition Corporation II	0.03%	Hold	600,000	$10.22	$6.1M	—	—
Metals Acquisition	0.03%, was 0.01%	Add +160.4%	410,197	$13.69	$5.6M	+252,697	+$3.6M
CYTK, Cytokinetics	0.03%	Hold	102,400	$54.18	$5.5M	—	—
Metagenomi	0.03%	Hold	1,343,201	$4.08	$5.5M	—	—
NVAX, Novavax	0.02%	Reduce −66.6%	377,250	$12.66	$4.8M	−753,750	−$630K
RARE	0.02%	Hold	99,000	$41.10	$4.1M	—	—
PRME, Prime Medicine	0.02%	Hold	750,000	$5.14	$3.9M	—	—
COGT, Cogent Biosciences	0.02%	Reduce −8.0%	425,161	$8.43	$3.6M	−36,839	+$479K
Swiftmerge Acquisition	0.02%	Hold	300,000	$10.92	$3.3M	—	—
Berenson Acquisition	0.01%	Hold	285,715	$10.65	$3M	—	—
Biodesix	0.01%	New	1,878,175	$1.53	$2.9M	+1,878,175	+$2.9M
Arya Sciences Acqu Corporation IV	0.01%	Hold	200,000	$11.46	$2.3M	—	—
NRIX, Nurix Therapeutics	0.01%	New	108,799	$20.87	$2.3M	+108,799	+$2.3M
AMLX, Amylyx Pharmaceuticals	0.01%	Hold	1,150,221	$1.90	$2.2M	—	—
Summit Midstream Partners	0.01%	Hold	58,214	$35.56	$2.1M	—	—
Marblegate Acquisition	0.01%	Hold	150,000	$10.81	$1.6M	—	—
VNET, Vnet Group	0.01%	Hold	650,000	$2.10	$1.4M	—	—
QTRX, Quanterix	0.00%, was 0.05%	Reduce −83.0%	80,000	$13.21	$1.1M	−391,000	−$10M
Forte Biosciences	0.00%	Hold	1,810,455	$0.5370	$972K	—	—
MDGL, Madrigal Pharmaceuticals	0.00%	Hold	3,319	$280.16	$930K	—	—
Sage Therapeutics	0.00%	Hold	42,800	$10.86	$465K	—	—
Blueprint Medicines	0.00%	Hold	4,000	$107.78	$431K	—	—
Cara Therapeutics	0.00%	Hold	1,556,251	$0.2580	$402K	—	—
KRYS, Krystal Biotech	0.00%	Hold	2,000	$183.64	$367K	—	—
AXSM, Axsome Therapeutics	0.00%	Hold	4,000	$80.50	$322K	—	—
HCA, HCA Healthcare	0.00%	Hold	1,000	$321.28	$321K	—	—
GKOS, Glaukos	0.00%	Hold	2,600	$118.35	$308K	—	—
MMSI, Merit Medical Systems	0.00%	Hold	3,000	$85.95	$258K	—	—
EHC, Encompass Health	0.00%	Hold	3,000	$85.79	$257K	—	—
BTSG, Brightspring Health Services	0.00%	Hold	22,000	$11.36	$250K	—	—
ARQT, Arcutis Biotherapeutics	0.00%, was 0.08%	Reduce −98.5%	26,000	$9.30	$242K	−1,754,000	−$17M
HQY, Healthequity	0.00%	Hold	2,800	$86.20	$241K	—	—
APLS, Apellis Pharmaceuticals	0.00%	Hold	6,000	$38.36	$230K	—	—
IONS, Ionis Pharmaceuticals	0.00%, was 0.14%	Reduce −99.3%	4,800	$47.66	$229K	−729,200	−$32M
HUM, Humana	0.00%, was 0.08%	Reduce −98.8%	600	$373.65	$224K	−51,100	−$18M
ACLX, Arcellx	0.00%	Hold	4,000	$55.19	$221K	—	—
CHE, Chemed	0.00%	Hold	400	$542.58	$217K	—	—
SBRA, Sabra Health Care REIT	0.00%	Hold	14,000	$15.40	$216K	—	—
IOVA, Iovance Biotherapeutics	0.00%	Hold	26,000	$8.02	$209K	—	—
SNDX, Syndax Pharmaceuticals	0.00%	Hold	10,000	$20.53	$205K	—	—
RNA, Avidity Biosciences	0.00%, was 0.07%	Reduce −99.2%	5,000	$40.85	$204K	−601,061	−$15M
HIMS, Hims & Hers Health	0.00%, was 0.12%	Reduce −99.4%	10,000	$20.19	$202K	−1,666,000	−$26M
R1 RCM	0.00%	Hold	16,000	$12.56	$201K	—	—
PACB	0.00%, was 0.06%	Reduce −96.4%	135,000	$1.37	$185K	−3,637,452	−$14M
ALT, Altimmune	0.00%, was 0.02%	Reduce −94.1%	27,600	$6.65	$184K	−442,400	−$4.6M
GRFS, Grifols	0.00%	Hold	28,000	$6.30	$177K	—	—
OSCR, Oscar Health	0.00%	Hold	11,000	$15.82	$174K	—	—
ARDX, Ardelyx	0.00%	Hold	23,000	$7.41	$170K	—	—
FOLD, Amicus	0.00%	Hold	16,000	$9.92	$159K	—	—
CCCC, C4 Therapeutics	0.00%	Hold	28,000	$4.62	$129K	—	—
BYND, Beyond Meat	0.00%	Hold	19,000	$6.71	$127K	—	—
IRWD, Ironwood Pharmaceuticals	0.00%	Hold	13,000	$6.52	$85K	—	—
Lufax	0.00%	Reduce −90.0%	15,000	$2.37	$36K	−134,999	−$597K

Showing top 50 of 123 by value

Exits / last held

Gone since 2024 Q1, shown at their last reported size.

Stock	% of portfolio	Recent activity	Reported price*	Value	Share change	$ change
Pioneer Natural Resources	4.18%	Exit	$262.50	$924M	−3,520,000	−$924M
CSGP, CoStar Group	1.13%	Exit	$96.60	$251M	−2,594,356	−$251M
INSP, Inspire Medical Systems	0.61%	Exit	$214.79	$135M	−626,854	−$135M
VSTS, Vestis	0.43%	Exit	$19.27	$95M	−4,914,753	−$95M
GBTC, Grayscale Bitcoin Trust BTC	0.39%	Exit	$63.17	$85M	−1,349,077	−$85M
EVH, Evolent Health	0.15%	Exit	$32.79	$34M	−1,037,331	−$34M
BABA, Alibaba	0.11%	Exit	$72.36	$24M	−329,000	−$24M
APGE, Apogee Therapeutics	0.09%	Exit	$66.45	$20M	−305,000	−$20M
ASND, Ascendis Pharma A/s	0.07%	Exit	$151.17	$16M	−109,000	−$16M
Intra-Cellular Therapies	0.07%	Exit	$69.20	$16M	−231,000	−$16M
Immunome	0.07%	Exit	$24.68	$15M	−594,000	−$15M
Screaming Eagle Acquisitn	0.05%	Exit	$10.70	$11M	−1,000,000	−$11M
Cazoo Group	0.04%	Exit	$12.00	$8.6M	−714,240	−$8.6M
BRKR, Bruker	0.04%	Exit	$93.94	$7.8M	−83,100	−$7.8M
Gossamer Bio	0.03%	Exit	$1.18	$7.2M	−6,130,272	−$7.2M
PRAX	0.01%	Exit	$61.02	$3.1M	−50,000	−$3.1M
AVBP, Arrivent Biopharma	0.01%	Exit	$17.86	$2.7M	−151,768	−$2.7M
SLNO, Soleno Therapeutics	0.01%	Exit	$42.81	$1.2M	−27,750	−$1.2M
ALNY, Alnylam Pharmaceuticals	—	Exit	$149.50	$299K	−2,000	−$299K
Springworks Therapeutics	—	Exit	$49.20	$246K	−5,000	−$246K
Alpine Immune Sciences	—	Exit	$39.66	$234K	−5,900	−$234K
ACHC	—	Exit	$79.29	$222K	−2,800	−$222K
IDYA, Ideaya Biosciences	—	Exit	$43.80	$219K	−5,000	−$219K

Filings history

20 periods, with AUM normalized

Newest 13Fs

Period	Holds	AUM	QoQ	Form	Filed	Filing ID
2026 Q2	89	$21.7B	+23.6%	13F-HR	8/14/2026	000090883426000432
2026 Q1	1	$1.5B	—	new holds	8/14/2026	000090883426000434
2026 Q1	172	$17.5B	−17.2%	13F-HR	5/15/2026	000090883426000240
2025 Q4	1	$1B	—	new holds	8/14/2026	000090883426000433
2025 Q4	2	$884M	—	new holds	5/15/2026	000090883426000241
2025 Q4	151	$21.2B	−13.2%	13F-HR	2/17/2026	000090883426000087
2025 Q3	144	$24.4B	—	RESTATEMENT	2/17/2026	000090883426000086
2025 Q3	144	$24.4B	+5.4%	13F-HR	11/14/2025	000090883425000353
2025 Q2	1	$140M	—	new holds	2/17/2026	000090883426000085
2025 Q2	3	$483M	—	new holds	11/14/2025	000090883425000352
2025 Q2	141	$23.2B	+29.2%	13F-HR	8/14/2025	000090883425000248
2025 Q1	1	$274M	—	new holds	2/17/2026	000090883426000084
2025 Q1	3	$416M	—	new holds	11/14/2025	000090883425000351
2025 Q1	7	$2.2B	—	new holds	8/14/2025	000090883425000247
2025 Q1	135	$17.9B	−9.0%	13F-HR	5/15/2025	000090883425000177
2024 Q4	1	$85M	—	new holds	2/17/2026	000090883426000083
2024 Q4	2	$349M	—	new holds	11/14/2025	000090883425000350
2024 Q4	6	$2.3B	—	new holds	8/14/2025	000090883425000246
2024 Q4	4	$333M	—	new holds	5/15/2025	000090883425000180
2024 Q4	138	$19.7B	−3.5%	13F-HR	2/14/2025	000090883425000081
2024 Q3	1	$145M	—	new holds	11/14/2025	000090883425000349
2024 Q3	6	$1.5B	—	new holds	8/14/2025	000090883425000243
2024 Q3	3	$216M	—	new holds	5/15/2025	000090883425000179
2024 Q3	2	$544M	—	new holds	2/14/2025	000090883425000080
2024 Q3	153	$20.4B	−3.6%	13F-HR	11/14/2024	000090883424000307
2024 Q2	1	$120M	—	new holds	11/14/2025	000090883425000348
2024 Q2	5	$1.2B	—	new holds	8/14/2025	000090883425000245
2024 Q2	1	$199M	—	new holds	5/15/2025	000090883425000178
2024 Q2	2	$452M	—	new holds	2/14/2025	000090883425000079
2024 Q2	1	$149M	—	new holds	11/14/2024	000090883424000324
2024 Q2	157	$21.2B	−4.2%	13F-HR	8/14/2024	000090883424000200
2024 Q1	1	$93M	—	new holds	11/14/2025	000090883425000347
2024 Q1	4	$1.2B	—	new holds	8/14/2025	000090883425000244
2024 Q1	2	$159M	—	new holds	2/14/2025	000090883425000078
2024 Q1	1	$45M	—	new holds	8/14/2024	000090883424000202
2024 Q1	167	$22.1B	—	RESTATEMENT	5/24/2024	000090883424000159
2024 Q1	167	$22.1B	+9.8%	13F-HR	5/15/2024	000090883424000135
2023 Q4	1	$65M	—	new holds	11/14/2025	000090883425000346
2023 Q4	2	$548M	—	new holds	8/14/2025	000090883425000250
2023 Q4	5	$1.1B	—	new holds	5/15/2024	000090883424000141
2023 Q4	150	$20.1B	+1.0%	13F-HR	2/14/2024	000090883424000070
2023 Q3	1	$40M	—	new holds	11/14/2025	000090883425000345
2023 Q3	1	$40M	—	new holds	5/15/2024	000090883424000138
2023 Q3	2	$1.4B	—	new holds	2/14/2024	000090883424000077
2023 Q3	1	$1.9B	—	new holds	2/12/2024	000090883424000049
2023 Q3	159	$20B	+11.5%	13F-HR	11/14/2023	000090883423000150
2023 Q2	2	$669M	—	new holds	2/14/2024	000090883424000076
2023 Q2	5	$1.4B	—	new holds	11/14/2023	000090883423000157
2023 Q2	1	$1.2B	—	new holds	10/26/2023	000090883423000134
2023 Q2	165	$17.9B	+1.3%	13F-HR	8/14/2023	000090883423000109
2023 Q1	2	$234M	—	new holds	2/14/2024	000090883424000075
2023 Q1	3	$389M	—	new holds	11/14/2023	000090883423000156
2023 Q1	1	$15M	—	new holds	8/14/2023	000090883423000110
2023 Q1	187	$17.7B	+15.8%	13F-HR	5/15/2023	000117570723000127
2022 Q4	1	$171M	—	new holds	2/14/2024	000090883424000074
2022 Q4	3	$485M	—	new holds	11/14/2023	000090883423000155
2022 Q4	7	$1B	—	new holds	5/15/2023	000117570723000136
2022 Q4	232	$15.3B	−9.3%	13F-HR	2/14/2023	000117570723000051
2022 Q3	1	$125M	—	new holds	2/14/2024	000090883424000073
2022 Q3	3	$415M	—	new holds	11/14/2023	000090883423000154
2022 Q3	5	$411M	—	new holds	5/15/2023	000117570723000135
2022 Q3	4	$434M	—	new holds	2/14/2023	000090966123000005
2022 Q3	298	$16.8B	+3.5%	13F-HR	11/14/2022	000156761922019851
2022 Q2	1	$115M	—	new holds	2/14/2024	000090883424000081
2022 Q2	3	$411M	—	new holds	11/14/2023	000090883423000153
2022 Q2	2	$337M	—	new holds	5/15/2023	000117570723000134
2022 Q2	3	$136M	—	new holds	2/14/2023	000090966123000003
2022 Q2	9	$1.2B	—	new holds	11/14/2022	000156761922019862
2022 Q2	297	$16.3B	−13.7%	13F-HR	8/15/2022	000156761922015953
2022 Q1	1	$268M	—	new holds	11/14/2023	000090883423000152
2022 Q1	1	$314M	—	new holds	5/15/2023	000117570723000133
2022 Q1	1	$27M	—	new holds	2/14/2023	000090966123000002
2022 Q1	3	$186M	—	new holds	11/14/2022	000156761922019864
2022 Q1	8	$1.1B	—	new holds	8/15/2022	000156761922015972
2022 Q1	307	$18.8B	+0.4%	13F-HR	5/16/2022	000156761922010736
2021 Q4	1	$227M	—	new holds	5/15/2023	000117570723000132
2021 Q4	1	$7M	—	new holds	11/14/2022	000156761922019852
2021 Q4	1	$115M	—	new holds	8/15/2022	000156761922015968
2021 Q4	2	$98M	—	new holds	5/19/2022	000156761922011257
2021 Q4	6	$833M	—	new holds	5/16/2022	000156761922010757
2021 Q4	289	$18.7B	−5.1%	13F-HR	2/14/2022	000156761922003965
2021 Q3	1	$182M	—	new holds	5/15/2023	000117570723000131
2021 Q3	1	$105M	—	new holds	8/15/2022	000156761922015964
2021 Q3	1	$57M	—	new holds	5/19/2022	000156761922011256
2021 Q3	3	$998M	—	new holds	5/16/2022	000156761922010753
2021 Q3	2	$344M	—	new holds	2/14/2022	000156761922003981
2021 Q3	293	$19.7B	—	13F-HR	11/15/2021	000095012321015168

About

Farallon Capital Management, L.l.c.

87 processed 13Fs on this site, 2021 Q3 to 2026 Q2

SEC filing name: FARALLON CAPITAL MANAGEMENT, L.L.C.
Location: San Francisco, CA
All SEC filings: View on sec.gov